Fewer hospital CEOs are leaving their jobs, according to a report from Challenger, Gray & Christmas on CEO turnover. During the first four months of 2019, 26 hospital CEOs left their jobs, compared to 35 departures during the same time period in 2018.

AI has the potential to disrupt the healthcare industry and improve healthcare outcomes of patients through faster diagnosis and more accurate, targeted treatment. But how AI algorithms are trained needs some improvement, according to Naga Rayapati, founder and CEO/CTO at online marketplace GoGetter, which penned an article for Forbes.

President Trump announced principles to address the issue of surprise billing in healthcare, the White House announced May 9.

The savings that Medicare Advantage plans can bring to the table may have been over-weighted after a recent study revealed seniors who switch from traditional Medicare plans already have lower healthcare costs before they join an MA plan.

The FDA is putting an end to a program that allowed medical device companies to keep the public in the dark about reports of harm and malfunction. The program, called alternative summary reporting, was established in 1997 and its data has not been publicly available.

Adopting the prices of other countries could potentially have helped save Medicare part D as much as $72.8 billion in 2018, as drug prices in the U.S. averaged 3.2 to 4.1 times higher after rebates compared to the U.K., Japan and Ontario, Canada, according to a study published in Health Affairs.

HHS has finalized a rule that will require drug companies to publish the list prices of drugs in television ads. 

CMS is taking steps to streamline the review process for states that apply for section 1915 waivers and state plan amendments, CMS Administrator Seema Verma announced May 7.